AU2001294999A1 - Compositions and methods for the therapy and diagnosis of colon cancer - Google Patents

Compositions and methods for the therapy and diagnosis of colon cancer

Info

Publication number
AU2001294999A1
AU2001294999A1 AU2001294999A AU9499901A AU2001294999A1 AU 2001294999 A1 AU2001294999 A1 AU 2001294999A1 AU 2001294999 A AU2001294999 A AU 2001294999A AU 9499901 A AU9499901 A AU 9499901A AU 2001294999 A1 AU2001294999 A1 AU 2001294999A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294999A
Inventor
William T. Hepler
Yuqiu Jiang
Ruth A. Pyle
Jiangchun Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001294999A1 publication Critical patent/AU2001294999A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
AU2001294999A 2000-08-07 2001-08-07 Compositions and methods for the therapy and diagnosis of colon cancer Abandoned AU2001294999A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22365300P 2000-08-07 2000-08-07
US60/223,653 2000-08-07
US22382600P 2000-08-08 2000-08-08
US60/223,826 2000-08-08
PCT/US2001/041625 WO2002012332A2 (en) 2000-08-07 2001-08-07 Compositions and methods for the therapy and diagnosis of colon cancer

Publications (1)

Publication Number Publication Date
AU2001294999A1 true AU2001294999A1 (en) 2002-02-18

Family

ID=26917990

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294999A Abandoned AU2001294999A1 (en) 2000-08-07 2001-08-07 Compositions and methods for the therapy and diagnosis of colon cancer

Country Status (3)

Country Link
US (1) US20020142957A1 (en)
AU (1) AU2001294999A1 (en)
WO (1) WO2002012332A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004037860A1 (en) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker for the diagnosis of carcinomas and / or derived metastases
CA2662915A1 (en) * 2006-09-08 2008-03-13 Corixa Corporation Methods, compositions, and kits for the detection and monitoring of colon cancer
AU2016232866B2 (en) * 2015-03-17 2021-10-21 Omniox, Inc. Modulation of tumor immunity by protein-mediated 02 delivery
CN111125980B (en) * 2019-12-12 2023-06-02 杭州电子科技大学 Fractional order exponential memristor circuit model

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3538381B2 (en) * 1998-05-21 2004-06-14 ダイアデクスアス・インコーポレーテッド Novel method for diagnosing, monitoring and staging colon cancer
WO2000037643A2 (en) * 1998-12-23 2000-06-29 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US6262333B1 (en) * 1998-06-10 2001-07-17 Bayer Corporation Human genes and gene expression products
US6605433B1 (en) * 1998-08-20 2003-08-12 The Johns Hopkins University Mitochondrial dosimeter
JP2002523088A (en) * 1998-08-31 2002-07-30 バイエル コーポレイション Human genes differentially expressed in colon cancer
DE69938190T2 (en) * 1998-10-15 2009-03-05 Novartis Vaccines and Diagnostics, Inc., Emeryville GENES WITH CHANGED EXPRESSION IN METASTIC BREAST OR THICK-DARM CANCER CELLS
WO2001036685A2 (en) * 1999-11-17 2001-05-25 Nyxis Neurotherapies, Inc. Differential gene expression in cancer
WO2001049716A2 (en) * 1999-12-30 2001-07-12 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
EP1287028A2 (en) * 2000-06-09 2003-03-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
WO2002012332A3 (en) 2003-02-20
WO2002012332A2 (en) 2002-02-14
US20020142957A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer